For Research Purposes Only · Not For Human Consumption

Batch-Matched CoA Available
Research Use Only · Not For Human Consumption
Same-Day Dispatch from Manchester
Independently Tested · Accredited External Lab
Stored at −20°C Until Dispatch
Home/Buy/Semax 10mg
Semax 10mg vial
CoA verified

Nootropic / Cognitive Research

Semax 10mg

Semax peptide — a synthetic ACTH(4-10) analogue. Researched for BDNF expression, focus, memory and neuroprotection in preclinical models.

Vial size

Quantity

£24.99

In stock

Inc. VAT · Add £25.01 more for free UK shipping

How many
1
Order before 6pm Monday for same-day dispatch

SSL encrypted · CoA published for this lot

Delivery.
£3.99 Tracked 24, free over £50. Same-day dispatch before 6pm. Details
Payment.
Bank transfer, approved in your banking app. We never see your card or bank details.
Returns.
14 days if unopened. Damaged or wrong items replaced free. Policy
Verification.
Independently HPLC-tested. Signed CoA for this lot is on this page.

Certificate of Analysis

Semax 10mg

Independent lab
an accredited independent laboratory
Batch number
UKP-SEM-2512
Method
HPLC-UV + MS
Result
≥98% HPLC
Download CoA (PDF) — Semax 10mgView full Certificate of Analysis for batch UKP-SEM-2512

The CoA you download is the exact certificate produced for this lot — no edits.

Storage & handling

Keep it stable, keep it sterile

Sealed vial
-20°C, protect from light
Once reconstituted
Once reconstituted, store at 2–8°C (refrigerated). Use within 28 days. Do not refreeze after reconstitution.
Diluent
Bacteriostatic water (0.9% benzyl alcohol)
Shipping
Insulated, ice packs
+ Add Bacteriostatic Water (£1.99) →
FAQ

Semax 10mg — common questions

7 more questions
Research Compound

About Semax

Semax is a synthetic heptapeptide developed at the Russian Academy of Sciences, derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH(4-10)) with a Pro-Gly-Pro C-terminal extension for enzymatic stability. Extensively studied for BDNF and NGF upregulation, dopaminergic modulation and neuroprotective activity in in-vitro and preclinical models. ≥98% HPLC, third-party CoA on every batch.

Research areas

  • BDNF & NGF expression
  • Neuroprotection
  • Attention & memory
  • Dopaminergic modulation
  • Stroke recovery models
Compound Profile

Semax 10mg — mechanism, research applications & compound data

Semax peptide is a synthetic heptapeptide analogue of the N-terminal fragment of adrenocorticotropic hormone (ACTH(4-10)), developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Extensively researched for BDNF and NGF upregulation, dopaminergic modulation and neuroprotective activity in preclinical models.

UK Peptides supplies Semax 10mg as ≥98% HPLC lyophilised powder with a signed third-party Certificate of Analysis.

Read the full Semax technical profile (8 sections) →
01

Semax nasal spray vs lyophilised powder

Almost everyone searching for this compound types "Semax nasal spray", because in Russia — the only country where it is a registered medicine — Semax is dispensed as an intranasal solution. The peptide is not orally bioavailable, so the nasal route is how the licensed Russian product is given. What we supply is not that.

UK Peptides ships Semax as a lyophilised powder in a sealed vial, for in-vitro laboratory research. We do not sell a Semax nasal spray, Semax drops or Semax capsules, and nothing here is a medicine or a substitute for one. If you are researching the intranasal literature, the compound is the same heptapeptide — the presentation, the excipients and the regulatory status are not.

02

Semax peptide benefits reported in the research literature

What does Semax do? "Semax benefits" is one of the most searched phrases around this peptide, and the honest answer is that the evidence base is lopsided. Most clinical work sits in Russian-language journals, much of it predating modern trial-reporting standards, and very little has been replicated independently in the West. What the published research reports:

  • Rapid BDNF and NGF upregulation in hippocampal and cortical tissue (the most consistently replicated finding)
  • Neuroprotection in ischaemic and oxidative-injury models
  • Effects on attention and executive function in rodent behavioural paradigms
  • Dopaminergic and serotonergic modulation
  • Stroke-recovery outcomes in Russian clinical work, largely unreplicated outside Russia
03

Semax side effects and safety data

The Russian regulatory record describes Semax as well tolerated at the doses used in the registered intranasal product, and reported adverse effects in that literature are mild and local. That record is genuine, but it is also the weakest kind of evidence available in a Western framework: it is not backed by the placebo-controlled, independently audited trials the MHRA or EMA would require, and it does not cover the quantities or routes people use outside a clinic.

There is no MHRA safety assessment of Semax, because Semax has never been submitted for one. Absence of reported harm in a system that was not designed to detect it is not a safety finding.

04

Semax vs Selank: two Russian research peptides

Semax and Selank come from the same institute and are constantly compared, but they are not variants of one another. Semax is an ACTH(4-10) fragment extended with Pro-Gly-Pro and is studied mainly for BDNF/NGF expression and neuroprotection. Selank is built from tuftsin, an immunopeptide released from immunoglobulin G, and is studied mainly for anxiolytic and GABAergic endpoints.

Both carry the same Pro-Gly-Pro tail, which is a stability motif rather than a shared mechanism. We stock both, and the full comparison is in our Semax vs Selank guide.

05

Semax research applications

The 10mg vial supports typical research-scale protocols at standard reconstitution concentrations. Published research covers:

  • Attention, learning and memory models
  • BDNF and neurotrophic factor studies
  • Ischaemic stroke recovery models
  • ADHD and executive-function research
  • Neuroprotection in oxidative-stress paradigms
  • Comparison against Selank and related research nootropics
06

Storage and stability

Store the lyophilised vial at -20°C, sealed and protected from light. Refrigerate the reconstituted solution at 2–8°C and use within 28 days. Do not refreeze.

07

≥98% HPLC purity verified independently

Every Semax 10mg vial is independently HPLC-UV tested to ≥98% purity by an accredited independent laboratory, with mass-spectrometry identity confirmation against the published molecular weight of 813.94 Da. The signed PDF Certificate of Analysis is supplied with every order and matches the lot number on the vial.

08

Buying Semax peptide in the UK

The Semax for sale on this page is UK stock, held in Manchester and dispatched the same working day on orders placed before 6pm GMT. Semax UK delivery is Royal Mail Tracked 24 in insulated cold-chain packaging. This matters more than usual here: Semax is one of the most-counterfeited nootropic research peptides on the grey market, with under-dosed vials and outright substituted compounds widespread, and most of what is sold as Semax in the UK arrives from overseas with no batch-specific analysis at all.

Every lot we list is third-party HPLC verified before it goes on sale, and the signed CoA for the exact lot in your vial is downloadable from this page.

The science, in depth

Mechanism, the published evidence and handling detail for Semax are covered in full in our research library — 6 referenced articles rather than a summary on a product page.

References & further reading

Primary sources cited on this page

Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) analogue of the ACTH(4-10) fragment, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is on the World Health Organisation's International Nonproprietary Names list. Semax is registered as a medicine in the Russian Federation but is not licensed by the MHRA, EMA or FDA.

Sources & related pages

Regulatory & compliance notice

This product is supplied strictly for in-vitro laboratory research. It is not a licensed medicine in the United Kingdom, is not approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency for human or veterinary use, and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page constitutes medical advice.

Last reviewed 22 July 2026.

Research Library

Further reading on Semax

Peer-referenced articles from our research library covering mechanism, evidence and handling.

Every batch independently tested by an accredited independent laboratory before dispatch. The signed certificate for this lot is published on this page.

Third-party HPLC-UV testing Lot-matched CoA on every order Batch-traceable from dispatch

Legal notice

This product is sold strictly for in-vitro laboratory research purposes only. It is not approved for human or veterinary use, is not a drug, food, or cosmetic, and should not be misused as such. UK Peptides accepts no liability for misuse. By purchasing you confirm you are a qualified researcher aged 18 or over.

Semax 10mg

£24.99